Author: BioactiveCompoundLibrary

Spearman’s correlation coefficent was employed to assess whether the abundances of two taxa were independent or associated. Obesity is closely linked with insulin resistance, and increasing evidence suggests that reactive oxygen species generated in muscle mitochondria may impair insulin signalling in animal and cellular models. These studies have also shown that over – expression of muscle-specific antioxidant enzymes, or treatment with the mitochondrial superoxide dismutase mimetics and mitochondria-specific free radical scavengers, protects rodents from developing insulin resistance following high fat overfeeding. Whether sustained high fat overfeeding will elevate these markers in non-obese humans is not yet clear, although a single high fat meal increases mitochondrial ROS emission in lean and obese humans. Moreover, both systemic markers of oxidative stress and ROS production in skeletal muscle mitochondria are reported to be elevated in human obesity. A reduction in skeletal muscle mitochondrial number and/or maximal oxidative capacity is also reported in human obesity, aging and type 2 diabetes and is postulated to be causal in the development of obesity-associated insulin resistance. The mitochondrial dysfunction hypothesis of insulin resistance has arisen SCH772984 mainly from studies showing reduced expression of genes involved in mitochondrial biogenesis or reduced ATP production in healthy relatives of type 2 diabetes individuals. Reduced expression of genes involved in mitochondrial biogenesis is also observed following isocaloric high fat diet, or following prolonged lipid infusion with the parallel induction of peripheral insulin resistance in healthy humans. However, other studies have shown that mitochondrial dysfunction is not a prerequisite for insulin resistance in humans. Rodents that are fed a high fat diet for 4–20 weeks have increases in the more functional measures of skeletal muscle oxidative capacity, despite developing insulin resistance and diabetes. Together, these findings challenge the role of mitochondrial dysfunction as a primary factor in the development of insulin resistance. We, and others, have previously shown that short term overfeeding decreases the glucose infusion rate necessary to maintain euglycemia during a hyperinsulinemic-euglycemic clamp. In this study, we focused on factors in skeletal muscle that may contribute to the insulin resistance that was observed during overfeeding. The specific aims were to determine the effects of 3 and 28 days of overfeeding on skeletal muscle markers of oxidative stress, and mitochondrial content and function. We hypothesized that overfeeding would increase oxidative stress and this would be associated with a reduction in markers of mitochondrial content and function. Short term overfeeding reduces insulin sensitivity in healthy non-obese individuals, however the mechanisms underlying this are unclear. In this study, we report that whilst the reduction in insulin sensitivity following overfeeding was modest, it occurred without a reduction in any of the markers of mitochondrial content and function examined. However, we observed that systemic and skeletal muscle markers of oxidative stress were increased, and therefore may have contributed to the insulin resistance observed. The role of ROS in mediating insulin resistance is debated.

This is of particular interest because PMNs are the primary leukocyte involved in clearing bacteria corneal infections. Interestingly, it was shown that Staphylococcus aureus cells coated with serratamolide were also protected from PMN phagocytosis. This leads us to speculate that the presence of S. marcescens-derived serratamolide in contact lens cases or on lenses may better enable other pathogenic bacteria to establish ocular infections. It was noted that swrW was found in,35% of the tested ocular clinical isolates, and 40% of the swrW containing isolates were hemolysis positive on blood agar plates, suggesting that hemolytic strains express swrW sufficiently to produce hemolysis. In support of this premise, mutation of swrW in three out of five hemolysis positive strains severely reduced or eliminated hemolysis zones on blood agar plates. Of the swrW negative strains, 42% were hemolysis positive, indicating that other mechanisms of hemolysis are present in ocular clinical isolates. Another gene, swrA, present in some strains of S. marcescens is necessary for production of serrawettin W2, may account for the hemolysis positive phenotype of swrW negative strains. There is genetic evidence that the swrA-dependent product serrawettin W2, a structurally distinct surfactant, can act as a hemolytic agent. Serrawettin W2, consisting of five amino acids with a single acyl chain, is detected by Caenorhabditis elegans as a chemical signal to avoid S. marcescens colonies. Transposon mutation of the swrA gene, in strain Db10, led to the loss of hemolysis zones on blood agar plates that was correlated with the loss of serrawettin W2. Whereas the hemolysis and cytotoxicity data presented here suggest that serratamolide may contribute to bacterial infections, the absence of the swrW gene in many pathogenic and contact lens associated strains indicate that SwrW is not a requirement for colonization of contact lenses or for causing ocular diseases. Serratamolide may be more relevant in environmental settings than for human infections, as the majority of pigmented strains tested had the swrW gene, and pigmentation is generally associated with environmental isolates, whereas clinical isolates are almost exclusively non-pigmented. In an environmental setting serratamolide could contribute to the competitiveness of S. marcescens as it is a broad spectrum antibiotic. Furthermore, it was shown that a surfactant produced by Serratia sp. ATCC 39006 facilitates the dispersal of the antibiotic pigment prodigiosin, and serratamolide may act in an analogous fashion. Serratamolide has shown promise as an anticancer agent for its proapoptotic effect upon breast cancer and B-cell chronic lymphocytic leukemia cells. Therefore, understanding the pathways that control serratamolide production may yield improved ways to generate this cyclodepsipeptide. Further studies will focus on determining the regulatory pathway by which CRP regulates serratamolide production, and characterizing the role this surfactant plays in host-pathogen interactions. The life cycle of Plasmodium takes place in a Torin 1 vertebrate and in an insect host. When the mosquito takes up a bloodmeal from an infected host, it ingests sexual stages of Plasmodium, the gametocytes. In the mosquito, the gametocytes develop into gametes which fertilise to form a zygote.

For instance, it is interesting to speculate that the four conserved interferonstimulated bottlenecks may jointly control the regulation of different overlapping aspects of the interferon response, similar to the complex regulation seen in some pathogens. Further, the topological properties of the bottleneck genes indicate that they may drive downstream processes either directly or indirectly, and that the downstream processes should be reGSK2118436 presented in their network neighborhood. Thus abrogating the expression of a bottleneck gene should have an impact on the expression of some or all of its neighbors. We showed this to be true in the case of Ifit1. When the expression of Ifit1 is suppressed using siRNA in macrophage cells, the expression of downstream genes Usp18 and M61 were also suppressed in response to LPS. This supports the relationship between Ifit1 and its predicted first-order network, implicating Ifit1 as a functional bottleneck that affects downstream processes. The data presented here indicate that the bio-surfactant serratamolide can act as a novel S. marcescens hemolysin, and that the non-ribosomal peptide synthetase SwrW is necessary for hemolysis in some clinical and laboratory strains. Elevated in crp and hexS mutants that over-express swrW. Biochemical data indicate that purified serratamolide is sufficient to lyse red blood cells and damage epithelial cells in vitro. Genetic data suggests that serratamolide production is regulated by cAMP-CRP in strain CMS376, namely that surfactant zones are increased in a crp mutant and hemolysis is increased in mutant strains with altered ability to respond to or make cAMP. Since the cAMP-CRP pathway is well known to regulate genes in response to the nutritional environment of the cell, this may indicate that serratamolide plays a role in a bacterium’s ability to acquire or compete for nutrients. Consistent with the role of serratamolide in competition, it has been shown that serratamolide has antimicrobial activity against both prokaryotes and fungi, and that swarming motility, which requires biosurfactants such as serratamolide, confers resistance to antibiotics. Another role for serratamolide was suggested by BarrNess and colleagues. They showed that mutant strains deficient in serratamolide had reduced surface hydrophobicity, and the authors suggested that the highly hydrophobic surface of S. marcescencs contributes to its dispersal in the environment and virulence. Lipopeptide surfactants, such as surfactin from Bacillus species and syringomycins from Pseudomonas species can act as hemolysins. Serramic acid, another S. marcescens product was shown to be hemolytic to human and horse red blood cells, but only poorly hemolytic to bovine and sheep red blood cells. This same study tested serratamolide for hemolytic activity against human red blood cells, and the result was negative. The differences between this current study and the previously described study, in which serratamolide was tested for hemolysis, may be due to experimental differences, in that the previous authors delivered serratamolide using liposomes composed of several phospholipids, rather than serratamolide alone. Furthermore, the previous study tested serratamolide against human red blood cells but not sheep or murine red blood cells; it is possible that differences in membrane phospholipid composition or surface proteins may result in differential hemolytic activity.

In fact the existence of other genetic factors conferring susceptibility to HSCR in specific populations has been repeatedly reported. For instance, it has been reported that there exist two different RET haplotypes encompassing the enhancer mutation that are over-transmitted to the HSCR offspring in Caucasian populations, while in the Chinese sample only one of those haplotypes was present. A possible explanation was that the enhancer mutation arose on one haplotype which, after the Asian-European split, rearranged to give also the other haplotype, but exclusively in the European part. A similar hypothesis could be forwarded to explain the NRG1 effects in the Chinese population, being this supported by the fact that great differences are observed among the frequencies of the studied variants between both populations. That difference among Caucasian and Asian populations had been recently corroborated by a recent genotyping study in Thai population, where the genetic XAV939 Wnt/beta-catenin inhibitor variation of the RET-protooncogene and NRG1 is involved in the risk of HSCR development in the Thai population. Previous studies had indicated that NRG1 is a signalling protein that mediates cell-cell interactions and it is essential for the development and function of multiple organ systems and its dysregulation has been linked to diseases such as breast cancer, schizophrenia and HSCR. In addition, it has been shown that not only common, but also rare variants of the NRG1 gene contribute to HSCR. Here we report some novel variants located within the non-coding region although after bioinformatic predictions we failed to find that any of those variants would affect neither the splicing process nor the formation or modification of a transcription factor binding site in the DNA sequence. Furthermore, we report three new missense mutations as probably causing mutations for HSCR. Those variants were located on functional domains within the protein and all of them were found totally absent in control population. After functional approaches, we found that M111T, R438H and M139I mutant proteins induced a significant reduction in the quantity of the normal NRG1 protein levels in cells expressing them. In fact, our in silico predictions revealed that M111T and R438H would be probably damaging. Two of the affected residues in the NRG1 protein were located at the extracellular domain and the other one, R438H, was located at the cytoplasmic domain. The Ig-like domain in NRGs proteins could act in the process of attenuation of signalling through ErbB receptors, promoting the internalization and degradation of the complex ligand-receptor. This could be a control mechanism of the NRGs biological activity limiting their ability to diffuse freely and allowing the intracellular accumulation of these proteins to act quickly after being processed. The variant M111T detected at this domain would influence this process of attenuation which would explain the significant reduction of NRG1 level detected in cell lysates and the absence of differences obtained in the conditioned media. In addition, there are two important facts to mention about M111T variant: First, the change of a methionine by a threonine means that it is a non-conservative mutation. This aminoacidic change would alter structures and/or functions of NRG1 protein, as we can guess by functional approaches.

This increase in hepatic copper in six weekold Commd1Dhep mice probably results from residual copper pools accumulated in the preweaning period. Dietary studies have not been reported in Bedlington terriers with the homozygous COMMD1 deletion, but since most commercial dog food contains copper levels that exceed the minimum recommended daily intake, together with the presented data, suggest that reducing the gastrointestinal copper uptake by decreasing the dietary copper content would be beneficial to the liver pathology of affected dogs. Although our mouse model partially recapitulates the copper CHIR-99021 abmole accumulation phenotype of Bedlington terriers affected with CT, the exact mode of COMMD1 action in regulating hepatic copper metabolism remains elusive. However, several assumptions can be drawn from our data. Similar to Bedlington terriers, hepatic Commd1 deficiency in mice does not affect the incorporation of copper into Cp by Atp7b. Importantly, probably due to the increased bioavailable hepatic copper, the biosynthesis of holoceruloplasmin was even enhanced in middle-aged Commd1Dhep mice fed a copper-enriched diet compared to controls. Together with the observation that the copper-induced trafficking of ATP7B to the cell periphery is unaffected in COMMD1-deficient cells, it is tempting to speculate that, in excess copper, COMMD1 acts downstream of ATP7B and might be involved in the final step of the secretory pathway to efficiently release copper into the bile. This idea is further supported by the fact that COMMD1 partly localizes to vesicles of the endocytic pathway and cellular membranes, and shows only limited co-localization with ATP7B in HepG2 cells. However, COMMD1 is also implicated in regulating the protein levels of ATP7B. Whereas we previously demonstrated that COMMD1 expression augments the protein degradation of ATP7B in vitro, others have shown a decline in Atp7b expression after depletion of Commd1 in the mouse hepatoma Hepa1-6 cells. In line with this latter observation, a marked decrease in hepatic Atp7b in six week-old Commd1Dhep mice was observed, and may account for the increased hepatic copper levels observed in these animals. However, no correlation was seen between the degree of copper accumulation and Atp7b levels in Commd1Dhep mice fed a copperenriched diet, which argues against the role of impaired Atp7b protein stability in progressive copper accumulation in Commd1- deficient hepatocytes. Additionally, no discrepancies in Atp7b stability in primary Commd1-deficient hepatocytes compared to WT control cells were seen. Altogether, our data indicate that COMMD1 controls hepatic copper homeostasis downstream of ATP7B and may participate in the release of copper into the bile. Further studies are however needed to complete our understanding on the molecular function of COMMD1 in hepatic copper homeostasis. Interestingly, although Commd1Dhep mice fed a copper-enriched diet displayed a progressive increase in hepatic copper, no obvious liver pathology using histological analysis were seen, even after chronic exposure to high dietary copper. These data, supported by biochemical parameters and together with the observation that the mRNA expression of the copper-responsive genes Mt-I and Mt-II was only increased.